Corporate Social Responsibility (CSR) Policy

Preamble

At Bristol Pharma, our vision is to serve society by providing high-quality and affordable medicines, with a strong focus on reaching rural areas across India. We recognize that sustainable development requires a collaborative effort between the public and private sectors. As a responsible corporate, we are committed to contributing to national growth by utilizing our resources, innovation, and dedication to social betterment.

Our CSR approach is guided by ethical standards and compassion. We believe in creating a positive impact beyond business goals—uplifting lives, protecting the environment, and promoting inclusive development.

Our CSR Vision

“To actively contribute to the social and economic development of the communities in which we operate, thereby building a better, sustainable way of life for the weaker sections of society and raising the country’s human development index.”

Bristol Pharma has made a tangible impact in the areas of education, sanitation, rural healthcare, preventive care, and sports promotion—improving lives and communities at large.

Scope and Coverage

This CSR Policy covers planning, implementation, monitoring, and reporting of all CSR activities undertaken by Bristol Pharma within India. It excludes activities under normal business operations or those meant solely for employees and their families, in compliance with the Companies Act, 2013.

CSR Committee

In line with Section 135 of the Companies Act, 2013, the Board has formed a CSR Committee consisting of two executive directors and one independent director. This committee is responsible for:

• Formulating the CSR policy
• Identifying and recommending CSR activities
• Suggesting annual CSR expenditure
• Monitoring CSR initiatives
• Preparing the Annual Action Plan

CSR Focus Areas

As per Schedule VII of the Companies Act, Bristol Pharma’s CSR activities focus on:

• Eradicating hunger, malnutrition, and promoting healthcare & sanitation
• Supporting education and vocational training for underprivileged groups
• Promoting gender equality and empowering women
• Environmental sustainability and conservation efforts
• Protecting cultural heritage and traditional arts
• Supporting armed forces veterans and their families
• Promoting rural and Olympic-level sports
• Disaster relief and rehabilitation
• Research & development in science, tech, and healthcare
• Development of rural and slum areas

CSR Expenditure

Bristol Pharma shall spend at least 2% of the average net profits of the last three financial years on CSR activities. Any surplus arising from CSR projects will be reinvested into CSR efforts and not treated as company profit.

Capacity Building

The company will build internal CSR capabilities by training personnel and, where necessary, partnering with experienced external agencies. Expenses for capacity building will comply with statutory limits.

Monitoring and Review

The CSR Committee will oversee project implementation and review progress regularly. Monitoring will focus on expenditure, geographical reach, and project impact to ensure transparency and effectiveness.

Guiding Principles

A. Selection

• Activities must align with Schedule VII of the Companies Act
• Priority to local communities where Bristol Pharma operates
• Transparent, inclusive selection with local consultations if needed

B. Implementation

• Activities may be implemented directly or through approved agencies
• Maintaining quality standards throughout execution

C. Monitoring

• Real-time monitoring with feedback mechanisms
• Performance reviews by CSR Committee and designated teams

D. Annual Action Plan

• List of approved CSR projects
• Execution methods and fund utilization
• Monitoring and reporting framework
• Need and impact assessments (if applicable)

The Board may revise the Annual Action Plan based on CSR Committee recommendations and changing needs.

Disclosure

The CSR policy and updates will be available in the Board’s Report and on our website: www.bristolpharma.in